Results 231 to 240 of about 85,877 (261)

Management of Multidrug-Resistant Tuberculosis

Seminars in Respiratory and Critical Care Medicine, 2013
AbstractDrug-resistant strains of Mycobacterium tuberculosis pose a major threat to global tuberculosis control. Despite the availability of curative antituberculosis therapy for nearly half a century, inappropriate and inadequate treatment of tuberculosis, as well as unchecked transmission of M.
Charles L, Daley, Jose A, Caminero
openaire   +3 more sources

Multidrug-Resistant Tuberculosis

New England Journal of Medicine, 1992
Excerpt As recently as 10 years ago, tuberculosis was rapidly disappearing from the United States.
Samuel W. Dooley, William R. Jarvis, William J. Marione, Dixie E. Snider   +3 more
openaire   +2 more sources

Multidrug-resistant tuberculosis

2014
Abstract Multidrug-resistant tuberculosis (MDR-TB) is increasingly being identified around the world. Treatment options are limited due to the lack of new anti-mycobacterial agents and the side-effect profiles of currently available options.
Caoimhe Nic Fhogartaigh, Mike Brown
openaire   +1 more source

[Multidrug-resistant tuberculosis].

Presse medicale (Paris, France : 1983), 1996
The quality of diagnosis and therapeutic management affects the frequency of multiresistant tuberculosis observed in a given country. In 1991, physicians in the United States were faced with a large number of cases of multiresistant tuberculosis in patients with acquired immune deficiency syndrome, leading to international public health measures ...
openaire   +3 more sources

Multidrug resistant tuberculosis

Pathology, 2011
Multidrug resistant tuberculosis (MDRTB) and extensively resistant TB (XDRTB) are an increasing problem worldwide, especially in resource-poor nations. MDRTB is associated with vastly increased therapeutic costs and increased treatment failure rates.
openaire   +1 more source

Multidrug-Resistant Tuberculosis

Infectious Diseases in Clinical Practice, 1997
Jonathan Shuter, Eran Bellin
  +4 more sources

Anti-tuberculosis treatment strategies and drug development: challenges and priorities

Nature Reviews Microbiology, 2022
Véronique A Dartois, Eric J Rubin
exaly  

Immune evasion and provocation by Mycobacterium tuberculosis

Nature Reviews Microbiology, 2022
Pallavi Chandra, Steven J Grigsby, Jennifer A Philips   +2 more
exaly  

Enhancing global access to cancer medicines

Ca-A Cancer Journal for Clinicians, 2020
Javier Cortes, Giuseppe Curigliano, Nagi S El Saghir   +2 more
exaly  

Multidrug Resistant Tuberculosis

MCN, The American Journal of Maternal/Child Nursing, 1993
openaire   +2 more sources